Area of research
Epidemiology · Immunology
Research interest
Research interests include Autophagy in Disease and Therapy, Neutrophil, Myeloperoxidase and Oxidative Mechanisms, Telomeres, Telomerase, and Senescence, and Cannabis and Cannabinoid Research.
Acyl-CoA-binding protein as a driver of pathological aging
Early vascular aging in chronic kidney disease: focus on microvascular maintenance, senescence signature and potential therapeutics
Meta-hallmarks of aging and cancer
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Cellular senescence and the host immune system in aging and age-related disorders
COPI vesicle formation and N-myristoylation are targetable vulnerabilities of senescent cells
Vitamin B12 is a limiting factor for induced cellular plasticity and tissue repair
Recent insights into the crosstalk between senescent cells and CD8 T lymphocytes
Human senescent fibroblasts trigger progressive lung fibrosis in mice
Global and Spatial Metabolomics of Individual Cells Using a Tapered Pneumatically Assisted nano-DESI Probe
Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity
ACBP/DBI protein neutralization confers autophagy-dependent organ protection through inhibition of cell loss, inflammation, and fibrosis
Autophagy in major human diseases
Targeting Autophagy to Counteract Obesity-Associated Oxidative Stress
Autophagy in the cancer-immunity dialogue
3,4‐Dimethoxychalcone induces autophagy through activation of the transcription factors TFE3 and TFEB
Comprehensive autophagy evaluation in cardiac disease models
α-Ketoglutarate inhibits autophagy
Spermidine in health and disease
Aspirin Recapitulates Features of Caloric Restriction
Metabolic effects of fasting on human and mouse blood in vivo
Dietary spermidine for lowering high blood pressure
Autophagy in natural and therapy-driven anticancer immunosurveillance
Cardioprotection and lifespan extension by the natural polyamine spermidine
Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy
Autophagy in malignant transformation and cancer progression
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
Metabolic Control of Autophagy